We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+5.89%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$53.6B
AUM Growth
+$2.66B
Cap. Flow
+$86.8M
Cap. Flow %
0.16%
Top 10 Hldgs %
37.17%
Holding
821
New
56
Increased
227
Reduced
258
Closed
253

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$86.2M
2
ALC icon
Alcon
ALC
+$81.8M
3
NVDA icon
NVIDIA
NVDA
+$76M
4
GLW icon
Corning
GLW
+$50.4M
5
UNH icon
UnitedHealth
UNH
+$42.3M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$67.4M
2
FDS icon
Factset
FDS
+$62M
3
EEFT icon
Euronet Worldwide
EEFT
+$42.3M
4
BAC.PRL icon
Bank of America Series L
BAC.PRL
+$39.5M
5
OPLN
Openlane
OPLN
+$31.3M

Sector Composition

Rank Sector Weight
1 Technology 20.75%
2 Consumer Discretionary 17.74%
3 Financials 11.65%
4 Healthcare 11.2%
5 Communication Services 10.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWM icon
526
iShares Russell 2000 ETF
IWM
$83B
$1K ﹤0.01%
+9
New +$1.39K
IWO icon
527
iShares Russell 2000 Growth ETF
IWO
$15.1B
$1K ﹤0.01%
+7
New +$1.38K
XLE icon
528
State Street Energy Select Sector SPDR ETF
XLE
$37.7B
$1K ﹤0.01%
+36
New +$1.15K
XLF icon
529
State Street Financial Select Sector SPDR ETF
XLF
$58.2B
$1K ﹤0.01%
+48
New +$1.3K
XLK icon
530
State Street Technology Select Sector SPDR ETF
XLK
$124B
$1K ﹤0.01%
+36
New +$1.37K
XLV icon
531
State Street Health Care Select Sector SPDR ETF
XLV
$42.7B
$1K ﹤0.01%
+15
New +$1.35K
XLY icon
532
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
$1K ﹤0.01%
+24
New +$1.4K
A icon
533
Agilent Technologies
A
$41.2B
-176
Closed -$14K
ABR icon
534
Arbor Realty Trust
ABR
$998M
-18
Closed
AEE icon
535
Ameren
AEE
$30.1B
-219
Closed -$16K
AFG icon
536
American Financial Group
AFG
$12.1B
-4,824
Closed -$464K
AGCO icon
537
AGCO
AGCO
$7.2B
-383
Closed -$27K
AGO icon
538
Assured Guaranty
AGO
$3.34B
-200
Closed -$9K
AIV
539
Aimco
AIV
$383M
-796
Closed -$5K
AKAM icon
540
Akamai
AKAM
$15.9B
-356
Closed -$26K
OSG
541
Octave Specialty Group
OSG
$222M
-1,264
Closed -$23K
AMKR icon
542
Amkor Technology
AMKR
$13.7B
-1,632
Closed -$14K
AMPH icon
543
Amphastar Pharmaceuticals
AMPH
$916M
-978
Closed -$20K
APAM icon
544
Artisan Partners
APAM
$3.02B
-755
Closed -$19K
APLE icon
545
Apple Hospitality REIT
APLE
$3.82B
-538
Closed -$9K
ARCB icon
546
ArcBest
ARCB
$3.08B
-296
Closed -$9K
ARI
547
Apollo Commercial Real Estate
ARI
$885M
-886
Closed -$16K
CVSA
548
Covista Inc
CVSA
$4.8B
-137,644
Closed -$6.38M
ATKR icon
549
Atkore
ATKR
$3.16B
-687
Closed -$15K
AVA icon
550
Avista
AVA
$3.24B
-617
Closed -$25K

Similar funds

Loomis, Sayles & Company's Q2 2019 Portfolio in Review

As of Q2 2019, Loomis, Sayles & Company held 821 positions worth $53.6B, up 5.2% from $50.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Loomis, Sayles & Company's Q2 2019 filing shows 56 new, 227 increased, 258 reduced and 253 closed positions. Its largest new stake was Alcon: 1,393,674 shares worth $86.5M. The largest sale was Novartis, an estimated $67.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Loomis, Sayles & Company's largest Q2 2019 buy was Alcon: 1,393,674 shares worth $86.5M.
  • Loomis, Sayles & Company added most to Bristol-Myers Squibb in Q2 2019, an estimated $86.2M increase.
  • Loomis, Sayles & Company's biggest Q2 2019 reduction was Novartis, cutting an estimated $67.4M.
  • Loomis, Sayles & Company fully exited RingCentral in Q2 2019, selling an estimated $30.4M.
  • Loomis, Sayles & Company's ten largest holdings make up 37% of its $53.6B portfolio in Q2 2019.
  • Loomis, Sayles & Company opened 56 new positions and closed 253 in Q2 2019.
  • Loomis, Sayles & Company's portfolio value rose 5.2% quarter-over-quarter to $53.6B.

Based on Loomis, Sayles & Company's 13F filing for Q2 2019, filed 14 Aug 2019.